TABLE 4.
Area under the receiver operator characteristic curve (AUC) for glycated hemoglobin and fasting glucose for retinopathy*
| Overall | No diabetes | Diabetes | |
|---|---|---|---|
| Glycated hemoglobin | |||
| Any retinopathy (ETDRS ≥14) | 0.688 (0.658–0.718) | 0.561 (0.527–0.595) | 0.794 (0.753–0.834) |
| Mild retinopathy (ETDRS 14–20) | 0.585 (0.549–0.621) | 0.543 (0.506–0.580) | 0.733 (0.660–0.807) |
| Moderate to severe retinopathy (ETDRS ≥35) | 0.875 (0.837–0.913) | 0.658 (0.570–0.747) | 0.799 (0.756–0.843) |
| Fasting glucose | |||
| Any retinopathy (ETDRS ≥14) | 0.690 (0.660–0.720) | 0.565 (0.531–0.600) | 0.770 (0.728–0.812) |
| Mild retinopathy (ETDRS 14–20) | 0.598 (0.561–0.633) | 0.554 (0.517–0.592) | 0.738 (0.670–0.806) |
| Moderate to severe retinopathy (ETDRS ≥35) | 0.857 (0.816–0.897) | 0.622 (0.534–0.711) | 0.766 (0.717–0.815) |
Data are AUC (95% CI).
*Retinopathy was assessed at visit 3 in 1993–1995 (∼3 years after baseline).